[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
For Authors::
For Reviewers::
Subscription::
News & Events::
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE

:: ::
Back to the articles list Back to browse issues page
The synergistic role of ultrasound-guided interventions and radiotherapy in hepatocellular carcinoma: A meta-analysis of treatment outcomes
W. Zhao , Y. Liu , X. Li , G. Chen
Department of Ultrasound, Minda Hospital of Hubei Minzu University, Enshi, Hubei, China 445000 , 819136262@qq.com
Abstract:   (17 Views)
Background: To assess the effectiveness and safety of combining ultrasound-guided interventional therapy with radiotherapy (RT) in treating Hepatocellular Carcinoma (HCC). Materials and Methods: Literature was searched in PubMed, Coghlan's database and Web of Science (WOS) up to November 2024 without language restriction. Outcome indicators included complete response (CR), partial response (PR), stable disease (SD), disease progression (PD), 1-year survival rate, and adverse events (AEs). The Cochrane Collaboration tool was utilized to evaluate the risk of bias in the included studies. Statistical analysis was performed based on revman software, and P<0.05 was considered statistically significant. Results: Five studies were included in the analysis, and the overall quality of the studies was high. The combination therapy group demonstrated statistically significant differences compared to the control group in PR (OR=2.14, 95% CI: 1.32–3.48, P=0.002), PD (OR=0.45, 95% CI: 0.27–0.76, P=0.003), and AEs (OR=0.54, 95% CI: 0.35–0.82, P=0.004). No statistically significant differences were observed between the two groups in terms of CR (OR=1.31, 95% CI: 0.24–7.01, P=0.760), SD (OR=0.88, 95% CI: 0.50–1.55, P=0.670), and one-year survival rate (OR=1.62, 95% CI: 0.85–3.09, P=0.140). Conclusion: Ultrasound-guided interventional therapy combined with RT demonstrates certain clinical advantages in the treatment of HCC, particularly in improving PR, reducing PD, and managing AEs. Additional studies are required to confirm its long-term effectiveness and safety.
Keywords: Hepatocellular carcinoma, ultrasound-guided, radiotherapy, synergistic treatment, meta-analysis.
Full-Text [PDF 1308 kb]   (5 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Back to the articles list Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.06 seconds with 50 queries by YEKTAWEB 4718